News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

General Shareholders’ Meeting 2014

Dear Shareholders,

We invite you to attend the Annual General Shareholders’ Meeting of Epigenomics AG on Tuesday, June 3, 2014 at 10:00 a.m., in the premises of Deutsche Bank AG , Friedrichsaal, Unter den Linden 13–15 (entrance Charlottenstraße), 10117 Berlin.

Invitation to the Annual General Shareholders’ Meeting 2014 of Epigenomics AG PDF
Report of the Executive Board on agenda items 4 and 5 PDF
Report of the Executive Board on agenda item 6 PDF
Report of the Executive Board on agenda item 7 PDF
Annual Report 2013
(incl. Consolidated Financial Statements, Group Management Report, Supervisory Board Report, Key features of the internal control and risk management system and Remuneration Report)
PDF
Financial Statements 2013
(German HGB) incl. Key features of the internal control and risk management system (German version) 
PDF
Explanatory Report by the Management Board on Disclosures Pursuant to Section 289 (4), Section 315 (4) HGB (German version) PDF
Explanatory Report by the Management Board on Key Features of the Internal Control and Risk Management System Related to the Group Accounting Procedures of the Company Pursuant to Section 289 (5), Section 315 (2) HGB (German version) PDF

 

 

Corporate Governance/Declaration of Governance

2013
Declaration of Compliance with the German Corporate Governance Code pursuant to Section 161 of the German Stock Corporation Act (AktG) PDF
Declaration of Governance and reporting on Corporate Governance pursuant to Section 289a German Commercial Code (HGB) PDF

 

 

Further information

Explanation of Shareholders’ rights PDF
Articles of Association PDF
Form for the transfer of voting rights
(German version)
PDF

 

 

Review

Epigenomics AG held its 10th Annual General Shareholders’ Meeting in Berlin with about 50 shareholders, its representatives and guests on June 3, 2014. The presence before the voting was at 2,886,943 individual shares, equivalent to 21.368% of the share capital.

All agenda items were agreed to. More detailed information are available on our German website.